142 related articles for article (PubMed ID: 16617247)
1. Cystic Fibrosis testing among Arab-Americans.
Wei S; Feldman GL; Monaghan KG
Genet Med; 2006 Apr; 8(4):255-8. PubMed ID: 16617247
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis.
Strom CM; Crossley B; Buller-Buerkle A; Jarvis M; Quan F; Peng M; Muralidharan K; Pratt V; Redman JB; Sun W
Genet Med; 2011 Feb; 13(2):166-72. PubMed ID: 21068670
[TBL] [Abstract][Full Text] [Related]
3. Preconception and prenatal cystic fibrosis carrier screening of African Americans reveals unanticipated frequencies for specific mutations.
Monaghan KG; Bluhm D; Phillips M; Feldman GL
Genet Med; 2004; 6(3):141-4. PubMed ID: 15354332
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations.
Kambouris M; Banjar H; Moggari I; Nazer H; Al-Hamed M; Meyer BF
Eur J Pediatr; 2000 May; 159(5):303-9. PubMed ID: 10834512
[TBL] [Abstract][Full Text] [Related]
5. CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations.
Sugarman EA; Rohlfs EM; Silverman LM; Allitto BA
Genet Med; 2004; 6(5):392-9. PubMed ID: 15371903
[TBL] [Abstract][Full Text] [Related]
6. Dynamic modification strategy of the Israeli carrier screening protocol: inclusion of the Oriental Jewish Group to the cystic fibrosis panel.
Reish O; Borochowitz ZU; Adir V; Shohat M; Karpati M; Shtorch A; Orr-Urtreger A; Yaron Y; Shalev S; Fares F; Gershoni-Baruch R; Falik-Zaccai TC; Chapman-Shimshoni D
Genet Med; 2009 Feb; 11(2):101-3. PubMed ID: 19265749
[TBL] [Abstract][Full Text] [Related]
7. Genetic counselling after carrier detection by newborn screening when one parent carries DeltaF508 and the other R117H.
Curnow L; Savarirayan R; Massie J
Arch Dis Child; 2003 Oct; 88(10):886-8. PubMed ID: 14500307
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis carrier screening in a North American population.
Zvereff VV; Faruki H; Edwards M; Friedman KJ
Genet Med; 2014 Jul; 16(7):539-46. PubMed ID: 24357848
[TBL] [Abstract][Full Text] [Related]
9. Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population.
Kornreich R; Ekstein J; Edelmann L; Desnick RJ
Genet Med; 2004; 6(5):415-20. PubMed ID: 15371906
[TBL] [Abstract][Full Text] [Related]
10. Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center.
Wheeler PG; Smith R; Dorkin H; Parad RB; Comeau AM; Bianchi DW
Genet Med; 2001; 3(6):411-5. PubMed ID: 11715005
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
[TBL] [Abstract][Full Text] [Related]
12. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of cystic fibrosis mutations in Syrian patients.
Jarjour RA; Al-Berrawi S; Ammar S; Majdalawi R
Minerva Pediatr; 2018 Apr; 70(2):159-164. PubMed ID: 26041005
[TBL] [Abstract][Full Text] [Related]
14. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of common autosomal recessive mutation carriers in women in the Southern Vietnam following the application of expanded carrier screening.
To-Mai XH; Nguyen HT; Nguyen-Thi TT; Nguyen TV; Nguyen-Thi MN; Thai KQ; Lai MT; Nguyen TA
Sci Rep; 2024 Mar; 14(1):7461. PubMed ID: 38553482
[TBL] [Abstract][Full Text] [Related]
16. Carrier screening for cystic fibrosis.
Massie J
Lancet; 2009 Sep; 374(9694):978. PubMed ID: 19766881
[No Abstract] [Full Text] [Related]
17. Carrier screening for cystic fibrosis: a perinatal perspective.
Demsey SA
J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
[TBL] [Abstract][Full Text] [Related]
18. Current challenges in cystic fibrosis screening.
Lyon E; Miller C
Arch Pathol Lab Med; 2003 Sep; 127(9):1133-9. PubMed ID: 12946232
[TBL] [Abstract][Full Text] [Related]
19. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.
Abeliovich D; Lavon IP; Lerer I; Cohen T; Springer C; Avital A; Cutting GR
Am J Hum Genet; 1992 Nov; 51(5):951-6. PubMed ID: 1384328
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis carrier screening: steps in the development of a mutation panel.
Gilbert F
Genet Test; 2001; 5(3):223-7. PubMed ID: 11788088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
